Teradyne Stock in 2026: Is TER a Good Buy After Its 19% Earnings Crash?

Teradyne just reported record Q1 results — and the stock dropped nearly 20% in a single day. Here’s what the numbers actually tell you.

The semiconductor testing giant Teradyne (NASDAQ: TER) had a rough April 29. The company announced record Q1 2026 revenue, beat earnings estimates, and guided for a solid Q2 — and investors sold it off 19.4% anyway, dragging the stock down to $306.33. It’s now sitting below its 50-day moving average, well off its 52-week high of $422.11, and Wall Street is split on what comes next.

So what actually happened, and does Teradyne stock represent a buying opportunity at current prices? Let me walk through the data.

What Teradyne Actually Does — and Why It Matters for AI

Before getting into the valuation weeds, it’s worth understanding the business. Teradyne operates in three segments: Semiconductor Test, Robotics, and a smaller bucket covering defense/aerospace, circuit-board testing, and wireless systems.

The Semiconductor Test segment is the heart of the company. It builds the automated systems that test chips before they leave the factory — products used across automotive, smartphones, cloud computing, consumer electronics, and increasingly, AI accelerators. As AI data center buildouts accelerate, the demand for chip testing equipment goes with them.

Teradyne’s Q1 2026 earnings transcript made this connection explicit: CEO Gregory Smith cited “accelerating AI-driven demand across its businesses” while posting revenue of approximately $1.3 billion and non-GAAP EPS of $2.56 — both records for a first quarter.

The Robotics segment adds another growth layer, serving manufacturing and logistics customers with collaborative robotic arms and autonomous mobile robots. And on April 16, the company acquired TestInsight, a semiconductor test validation software developer, to tighten integration between chip design and testing workflows for AI hardware.

The business is real. The growth is real. The question is what you’re paying for it.

More From Tickzen –

• Is QCOM Stock a Good Investment in 2026? QUALCOMM Stock Analysis Reveals a Complex Picture
• Intel Stock Technical Analysis 2026: RSI at 82, a 63% Surge, and What Traders Should Do Next
• INTC Stock Analysis 2026: Is Intel Worth Buying After a 63% Rally?

Teradyne Q1 2026 Earnings: The Numbers Behind the Drop

The trailing twelve-month picture looks strong. Revenue came in at $3.19 billion, up 43.9% year-over-year. Net income hit $554 million, with earnings growing 81.4% year-over-year. Gross margin sits at 58.22%, and operating margin at 30.35%. The most recent quarter alone showed revenue of $1.08 billion — up 40.8% sequentially — with net income of $0.26 billion, up 114.2% quarter-over-quarter.

So why did TER stock fall nearly 20% on earnings day?

According to reporting from Motley Fool and Barron’s, the culprit was margin guidance. Despite the record revenue, management’s forward margin outlook came in softer than analysts expected. The stock market is forward-looking by design, and when a stock trades at a trailing P/E of 88.53x, there’s essentially no cushion for anything that reads as a step back — even a temporary one.

This is the core tension in the Teradyne investment case right now.

Teradyne Stock Valuation: Are You Paying Too Much?

At $306.33, Teradyne’s valuation metrics are stretched by almost any conventional measure.

• Trailing P/E: 88.53x — for context, the S&P 500 average is roughly 20–25x
• Forward P/E: 35.22x — more reasonable, but still pricing in strong execution
• Price/Sales: 15.03x
• EV/EBITDA: 73.24x — the report flags this as “extreme stretched valuation well beyond conventional norms”
• PEG Ratio: 2.10x — above 1.0 typically suggests a stock is overvalued relative to growth

The company’s enterprise value is $47.92 billion against a relatively small net cash position of $38.76 million. It’s not a distressed balance sheet — Teradyne carries $283.24 million in debt against $322 million in cash, and its 0.10x debt-to-equity ratio is conservative compared to peers like KLAC (1.12x) or Quantenna (0.61x). But the valuation multiple is doing a lot of work here.

The DCF model built into the analysis report is blunt about it. Using a 14.6% WACC and a 3.5% terminal growth rate, the base case implies a negative annual return of -14.5% per year if you buy at today’s price. The market is currently pricing in FCF growth of 84% per year over the next three years to justify $306.33. That’s not impossible given the AI tailwinds, but it’s a scenario where everything has to go right.

Teradyne Financial Health: What the Balance Sheet Actually Shows

This is where the Teradyne investment case gets more comfortable. Strip out the valuation multiples and the underlying business is well-run.

Return on Equity is 19.73%, Return on Assets is 10.83%, and Return on Invested Capital is 18.49%. These aren’t flashy numbers, but they’re consistent with a capital-efficient operation. Operating cash flow over the trailing twelve months came in at $674.41 million, and levered free cash flow at $270.63 million — enough to fund dividends, buybacks, and acquisitions without touching debt.

The Current Ratio of 1.75x and a Cash Conversion Cycle of 120.4 days are things to watch. It takes Teradyne about four months to convert inventory and receivables into cash. Days Sales Outstanding at 90.1 days suggests collections could be tightened. These aren’t alarm bells, but they’d be worth monitoring in a slower revenue environment.

The Altman Z-Score of 16.47x places the company firmly in “safe” territory for bankruptcy risk. Institutional ownership at 97.84% — nearly every share of the public float held by funds and institutions — is a sign that the largest, most data-driven investors in the world have broadly decided Teradyne is a legitimate business worth owning.

Teradyne vs. Peers: How TER Stacks Up in Semiconductor Equipment

The semiconductor equipment sector includes some of the largest companies in the technology world. Here’s how Teradyne sits against its closest competitors:

Teradyne is the fastest-growing company in this peer group by a wide margin — 43.9% revenue growth versus 23.8% for Lam Research and barely 7% for KLA. That growth rate partially explains the premium multiple. But the net margins tell a different story: LRCX converts 30.9% of revenue to net income, KLAC converts 35.76%, and Teradyne manages 17.37%. The company is growing fast but keeping less of each dollar than its larger peers.

ROE comparison is even starker. KLA Corporation’s ROE is 100.73%, Lam Research’s is 66.76%, and Teradyne’s is 19.73%. Some of the difference is leverage — KLAC and LRCX carry more debt — but it still shows that Teradyne’s capital efficiency has room to improve.

Teradyne Dividend: Not the Reason to Buy, But Worth Noting

Teradyne pays a $0.52 annual dividend, translating to a 0.14% yield at current prices. The payout ratio is just 13.83%, meaning the company uses less than 14 cents of every dollar earned to pay dividends. That’s a conservative posture that leaves plenty of room for future increases or reinvestment.

For context, the five-year average dividend yield was 0.39% — the current yield is depressed because the stock price ran up significantly. Income investors won’t be buying TER for its yield. Growth investors might note that the low payout ratio means a larger share of earnings is going back into the business.

Teradyne Stock Outlook 2026–2027: What Analysts Think

Seventeen analysts cover TER, and the consensus is Buy. The mean price target is $355.53, implying 16.1% upside from today’s $306.33. Targets range from $250 on the low end to $470 on the high end — a wide spread that reflects genuine uncertainty about how Q2 margins play out and how quickly AI-driven demand translates into sustained Semiconductor Test revenue.

The sentiment composite score is positive (0.26) but the confidence level is only 38%. Analyst sentiment is the dominant contributor (0.40 positive), while news and options market signals are roughly neutral.

The options market is pricing significant uncertainty. The nearest-expiry implied move is ±16.2% through May 29 — meaning the options market thinks there’s a realistic scenario where TER is either above $355 or below $257 within a month. ATM implied volatility sits at 72.3%, ranking in the 85th percentile of its 52-week range. Premium is expensive right now.

Should You Buy Teradyne Stock Right Now?

Here’s my read: Teradyne is a legitimately good business caught in the middle of a valuation problem.

The AI infrastructure buildout is real, and Teradyne is positioned in the right place — chip testing sits directly in the path of more semiconductor volume. The Q1 results were strong by any reasonable measure. The balance sheet is clean, debt is manageable, and the company generates substantial operating cash flow.

But the stock was priced for perfection before the earnings drop, and even at $306 it’s not cheap. An 88x trailing P/E and 73x EV/EBITDA leave almost no margin for a guidance miss, a macro slowdown, or a quarter where AI chip orders come in below expectations. The DCF model’s base case implies you lose money on a 10-year holding if growth doesn’t materialize exactly as hoped.

The 19% single-day drop creates a more interesting entry point than two weeks ago. But “more interesting than $422” isn’t the same as “cheap.” Long-term investors who believe in the AI infrastructure thesis and can stomach high volatility — beta is 1.79x, meaning TER swings roughly 79% harder than the market in both directions — might find the current price worth a position. The 200-day moving average at $206.90 is where the longer-term trend floor sits, and TER is comfortably above it.

For everyone else: wait for the 50-day moving average reclaim at $328.64, or a clearer signal that Q2 margins come in stronger than guided.

This article is for informational purposes only and does not constitute investment advice. Always do your own research and consult a qualified financial advisor before making investment decisions.